Chikungunya virus (CHIKV), an Old World alphavirus and Venezuelan equine encephalitis virus (VEEV), a New World alphavirus are the causative agents of debilitating diseases in humans. Over the past decade, CHIKV caused numerous outbreaks in the Asian and European countries and Americas making it an emerging pathogen bearing great global health importance. VEEV, on the other hand, has been developed as a bioweapon in the past due to its ease of preparation, aerosol dispersion and high lethality in aerosolized form. Currently, there are no FDA approved vaccines against these viruses. Live attenuated vaccines (V3526 and CHIKV 181/25) were developed against both VEEV and CHIKV but had to be retracted due to residual virulence in spite of being highly immunogenic during the clinical trials.
Introduction
The discovery and commercial development of a licensed lead vaccine candidate often requires decades of basic research followed by years of pre-clinical and clinical studies of safety and efficacy. Recent experiences with many pathogens including Ebola have highlighted the importance and requirement of developing vaccines much more rapidly. Due to the significantly greater time required for the discovery and testing of a subunit or live attenuated vaccine, the use of whole, inactivated preparations appear to be the most promising strategy for speedy deployment of first line of viral vaccines [1, 2] . DISTRIBUTION STATEMENT A: Approved for public release; distribution is unlimited.
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Gamma-irradiation is a classical virus inactivation method that is simple, economical and requires no additional purification steps [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] . It is also an FDAapproved method widely applied to sterilizing medical, dental, food and household
products. An irradiated-cryopreserved malaria vaccine, PfSPZ, is also currently under clinical trials [13] . Yet, the long-standing tenet of radiobiology that protein epitope destruction during irradiation is inevitable at doses needed to kill viruses has caused a setback to the development of irradiation-based approaches to vaccine production [1] [2] [3] .
During ionizing radiation (IR) exposure, the energy of the photons induces direct damage whereas the radiolysis of aqueous solution generating free radicals inflicts indirect damage [14] . IR induced direct damage indiscriminately targets both nucleic acids and proteins. However, it has been discovered that some extremely radiation resistant organisms have evolved mechanisms to specifically protect proteins from the far more damaging indirect effects of gamma (γ)-rays in aqueous preparations. Mn 2+ -peptide antioxidants that can uncouple protein and nucleic acid damage caused by γ-radiation were first reported in Deinococcus radiodurans, a naturally occurring radiation resistant extremophilic bacterium capable of surviving 12-16 kGy [15] . D. radiodurans, accumulates high concentration levels of manganese intracellularly in complex with other small metabolites and these complexes selectively preserve the intracellular proteins from oxidative damage under extreme environmental conditions leaving nucleic acids open to attack by reactive oxygen species (ROS) [15] [16] [17] . Subsequently, rational design of the peptide-component of these Mn antioxidants yielded a synthetic complex named MDP, which forms spontaneously when the synthetic decapeptide DEHGTAVMLK, orthophosphate (Pi) and Mn 2+ are combined. Under aqueous conditions, MDP preserved DISTRIBUTION STATEMENT A: Approved for public release; distribution is unlimited.
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6 the function of irradiated enzymes exposed to massive doses of γ-radiation (>50 kGy), but did not significantly protect DNA [18] . The recent discovery that MDP can protect the structural integrity of antigens at IR doses far above those which abolish infectivity of bacteriophage lambda has provided a new perspective to virus inactivation method that had been previously discounted due to its nonspecific destruction of the protein component [18, 19] .
For irradiated whole-virus vaccines, IR-induced destruction of a virus' genome is desired, while IR-induced damage to epitopes is counterproductive to the preservation of antigenic potency. In this study, the unique ability of MDP to uncouple protein damage from nucleic acid damage has been harnessed in alphaviruses exposed to supralethal doses of gamma-radiation (50 kGy). Alphaviruses are globally distributed arboviruses and are classified into New World and Old World alphaviruses [20] . Venezuelan equine encephalitis virus (VEEV), a New World alphavirus, is a potential bioweapon that is highly infectious in an aerosolized form. [21] [22] [23] . VEEV causes biphasic disease with initial replication in lymphoid and myeloid tissues followed by central nervous system infiltration initiating neuropathology and sometimes-fatal encephalitis [24] . In the past decades, VEEV has caused periodic enzootic outbreaks in Central and South America and the Americas [27] [28] [29] [30] . In 2014, thousands of CHIKV cases were reported throughout the United States with 11 locally transmitted cases in Florida, making it an emerging virus of significant public health importance [31] . At present, the lack of FDA-approved vaccines against either of these two arboviruses underscores the urgency for vaccine development. Earlier, V3526, a live-attenuated strain of VEEV, was developed by sitedirected mutagenesis based on the furin cleavage site deletion from PE2 glycoprotein and incorporation of a single amino acid mutation in the E1 glycoprotein [32, 33] . CHIK 181/25, a live-attenuated vaccine candidate for CHIKV, was developed by plaque-toplaque passaging [34, 35] . 
Results

Gamma irradiated virus gets inactivated in a radiation dose dependent manner.
Purified aqueous preparations of V3526 and CHIK 181/25 were mixed with or without MDP and exposed to increasing doses of gamma-irradiation (0-50 kGy) on ice. 
Gamma irradiated virus preparations caused no virulence in neonatal mice model.
The safety of the irradiated virus (+/-MDP) preparations was interrogated in vivo using the gold standard assay via intracranial inoculation in neonatal mice [4, 36] . The IR dose was chosen based on the in vitro results as only these doses were to be further tested 
Discussion
IR has long been exploited for vaccine development against a broad range of infectious agents [1, [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] . Although, the simplicity and absence of additional purification steps makes IR-based vaccine development attractive, the IR induced Thus, it is critical to be able to inactivate the viruses at supralethal doses of IR to confirm proper inactivation, but protect the antigenic proteins at the same time.
Studies on the underlying mechanisms of the exceptional radiation resistance of D. radiodurans, revealed the crucial role played by the intracellular Mn-small metabolite complexes as non-enzymatic ROS scavenging system specifically protecting the proteome [15, 16, 42] . Ultrafiltrates from this bacterium are enriched in such complexes and retain their radical oxygen scavenging properties (ROS) both in vitro and ex vivo [18, 43] . Mn-small metabolite complexes (such as MDP) when reconstituted in vitro based on their intracellular stochiometric concentrations, retain their exceptional ROS scavenging ability and can be applied to IR-based vaccine development [19, 44] .
Therefore, we exploited this unique strategy of developing IR-inactivated vaccines, where MDP was used during IR-inactivation of V3526 and CHIK 181/25 to uncouple the IR induced proteome damage from genome damage. The rationale behind using these live-attenuated strains of VEEV and CHIKV was that the elimination of their residual instability by IR in presence of MDP complex would result in the development DISTRIBUTION STATEMENT A: Approved for public release; distribution is unlimited.
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of highly efficacious inactivated vaccine candidates [45] [46] [47] [48] . Additionally, a number of earlier studies have already evaluated the underlying mechanisms and immune responses triggered by both these vaccines in detail [47, [49] [50] [51] [52] [53] .
In contrast to other recent gamma inactivation attempts where viruses were inactivated on dry ice, the viruses were kept on wet ice during gamma irradiation in our study [4, 54] . Although, dry ice reduces the IR-induced indirect damage mediated by ROS generation, this significantly increases the IR dose threshold required for complete genome inactivation [15, 54] . MDP complex is an excellent ROS scavenger that selectively protects the protein addressed the issue of preserving the epitope integrity 
Materials and Methods
Virus preparation
MDP complex and virus preparation for gamma-irradiation
The synthetic decapeptide (DP) H-Asp-Glu-His-Gly-Thr-Ala-Val-Met-Leu-Lys-OH was custom-synthesized with a peptide-purity of 95%. The net peptide content for each batch was determined by amino acid analysis performed at American Peptide Co. 
Virus titration
Virus titration was performed using the standard TCID 50 assay that determines the dilution at which 50% of cells in a culture are infected. Cell supernatant (10 μl) was subjected to ten-fold serial dilution in MEM/NCS media and 100 μl from each dilution was used for infection of 75% confluent Vero cell monolayer in 96 well plate. The 50% endpoint dilution was evaluated at 72 h post-incubation as described previously [60] .
Electrophoresis and western blot
Virus from control or test samples was resolved on 4-12% Bis-Tris gels hours, a second overlay of 0.6% agarose in DMEM containing 5% fetal bovine serum and neutral red was added and the plates were incubated at 37 o C, 5% CO 2 . Plaques were enumerated the following day. Virus infectivity was considered neutralized if the number of plaques was decreased by 80% compared to controls that contained fetal bovine serum.
RNA extraction and PCR amplification
Viral RNA isolation was done using PureLink Viral RNA/DNA Minikit 
Safety efficacy
Groups of neonatal CD-1 mice (n=5 to 10) were intracranialy (i.c.) injected with 5x10 4 pfu of viruses. Controls used for the study were non-irradiated virus, saline, and MDP complex. Mice were monitored daily for their weight and morbidity for a period of 12 days post-injection. The brain homogenate from the first passage (only V3526 irradiated to 40 kGy along with the V3526 control was selected for further testing) was intracranially passaged in a second set of suckling mice for similar observations. Animals were CO 2 euthanized followed by cervical dislocation at the end of study prior to collection of tissues (V3526: brain; CHIK 181/25: brain and knee).
Protective efficacy
Groups of female BALB/c mice (n=10) were intramuscularly (i.m.) immunized with 1 or 5 µg of the inactivated V3526 virus preparations on D0 and D28. Alhydrogel (alum) was also used as an adjuvant. Animals in control groups were administered with either saline, MDP complex or alum. VEEV C-84 IND was administered subcutaneously (s.c.) at 4 µg per mouse on D0, D7 and D28 as described previously [54] . Blood samples Mice with a clinical score of 5 and higher, displaying neurological signs like hind limb paralysis/circling or unresponsive when stimulated were considered unprotected and were DISTRIBUTION STATEMENT A: Approved for public release; distribution is unlimited.
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euthanized. Mice that survived for 3 weeks after challenge were considered protected and were euthanized at the end of the study.
Statistical analysis
Student's t-test was used for comparison between all the groups. For all data, statistical significance was accepted at p≤0.05.
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